Cargando…
MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer
To investigate the prognostic impact of MET copy number (MET-CN) in patients with non-small cell lung cancer (NSCLC), we retrospectively reviewed clinical and pathologic data of NSCLC patients whose tumors were assessed for MET-CN using fluorescence in situ hybridization (FISH). We correlated MET-CN...
Autores principales: | Fang, Lianghua, Chen, Hui, Tang, Zhenya, Kalhor, Neda, Liu, Ching-Hua, Yao, Hui, Hu, Shimin, Lin, Pei, Zhao, Jin, Luthra, Raja, Singh, Rajesh R., Routbort, Mark J., Hong, David, Medeiros, L. Jeffrey, Lu, Xinyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849187/ https://www.ncbi.nlm.nih.gov/pubmed/29560123 http://dx.doi.org/10.18632/oncotarget.24430 |
Ejemplares similares
-
MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome
por: Yin, Wei, et al.
Publicado: (2022) -
Receptor tyrosine kinase amplification is predictive of distant metastasis in patients with oral squamous cell carcinoma
por: Oikawa, Yu, et al.
Publicado: (2017) -
Inconsistent Intersample ALK FISH Results in Patients with Lung Cancer: Analysis of Potential Causes
por: Tang, Zhenya, et al.
Publicado: (2020) -
Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome
por: Guo, Peng, et al.
Publicado: (2017) -
Are patients fulfilling MET criteria recognized?
por: Hesselfeldt, R, et al.
Publicado: (2009)